PATENT CLAIM ANALYSIS

Application Number: 16068629
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
An embodiment of the invention relates to the use of stabilized cancer peptide fragments derived from Protocadherin FAT1 for the diagnosis of cancers, particularly pancreatic cancer. A method for the detection of cancer, severity of cancer, and/or effectiveness of a therapeutic regimen includes detecting and/or measuring the amount of Protocadherin FAT1 peptide fragments present in the biological sample of a subject.

Claim (Index 39):
The method of  claim 34 , wherein the biomolecule is an antibody or an antibody fragment.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 95.0
- Lexical Diversity: 1.60976
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14800162', '13384014', '13464174', '14671062', '13813680']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7605446382732136
- 35 USC 102 Novelty (BERT): 0.5405349134762212
- Combined Prediction Score: 0.7385436657935144
- Mean Citation Score: 313.977452
- Max Citation Score: 393.46048
- Similarity Product: 252.24026287261964

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test